Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| inhibits GABA-T-->higher levels of GABA, reduced membrane excitability |
|
|
Term
|
Definition
| competitive GABAa agonist (increased Cl- in the cell) |
|
|
Term
|
Definition
| GABAa antagonist (decreases opening frequency, less Cl- enters cell) |
|
|
Term
|
Definition
| GABAb receptor agonist (controls excessive motor movements, Huntington's disease) |
|
|
Term
|
Definition
| GABAb receptor antagonist (experimental) |
|
|
Term
|
Definition
| glycine receptor antagonist (causes massive excitation) |
|
|
Term
|
Definition
| presynaptic alpha 2 agonist, reduces NE lowers blood pressure |
|
|
Term
|
Definition
| inhibit NET, increased NE (ADHD) |
|
|
Term
|
Definition
| inhibit NET, increased NE |
|
|
Term
|
Definition
| 5-HT3 antagonist, prevents vomiting in cancer patients |
|
|
Term
|
Definition
| 5-HT1 agonist used to treat anxiety |
|
|
Term
|
Definition
Alzheimer's disease treatment
cholinesterase inhibitor, mild to moderate AD
may also act as a nicotinic and muscarinic (M1) agonist |
|
|
Term
|
Definition
Alzheimer's disease treatment
cholinesterase inhibitor, mild to moderate AD |
|
|
Term
|
Definition
Alzheimer's disease treatment
cholinesterase inhibitor, mild to moderate AD |
|
|
Term
|
Definition
Alzheimer's disease treatment
cholinesterase inhibitor, mild to moderate AD |
|
|
Term
|
Definition
Alzheimer's disease treatment
NMDA antagonist, moderate to severe AD |
|
|
Term
|
Definition
Parkinson's disease treatment
dopamine replacement drug
dopamine precursor |
|
|
Term
|
Definition
Parkinson's disease treatment
dopamine replacement drug
DOPA decarboxylase inhibitor (only in periphery) |
|
|
Term
|
Definition
Parkinson's disease treatment
dopamine replacement drug
COMT inhibitor (reduces breakdown of dopamine) |
|
|
Term
|
Definition
Parkinson's disease treatment
drug that mimics dopamine activity
D2 dopamine receptor agonist |
|
|
Term
|
Definition
Parkinson's disease treatment
drug that mimics dopamine activity
D1/D2 dopamine receptor agonist |
|
|
Term
|
Definition
Parkinson's disease treatment
antiviral |
|
|
Term
|
Definition
Parkinson's disease treatment
MAOi |
|
|
Term
|
Definition
Parkinson's disease treatment
muscarinic acetylcholine receptor antagonist |
|
|
Term
|
Definition
Parkinson's disease treatment
muscarinic acetylcholine receptor antagonist |
|
|
Term
|
Definition
Huntington's disease treatment
dopamine antagonist |
|
|
Term
|
Definition
Huntington's disease treatment
GABAb agonist |
|
|
Term
|
Definition
multiple sclerosis treatment
corticosteroid: decreases immune system antibody production and reduces myelin swelling and inflammation |
|
|
Term
|
Definition
multiple sclerosis treatment
regulates immune system |
|
|
Term
|
Definition
multiple sclerosis treatment
first non-interferon, non-steroidal medication that effectively reduces new brain lesions. |
|
|
Term
|
Definition
multiple sclerosis treatment
anticancer drug
suppresses activity of T cells, B cells, and macrophages that are thought to lead the attack on the myelin sheath. |
|
|
Term
|
Definition
inhaled anesthetic
potent anesthetic, weak analgesic |
|
|
Term
|
Definition
inhaled anesthetic
potent analgesic, weak anesthetic |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| neuromuscular blocker, blocks Ca channels, prevents hyperthermia |
|
|
Term
|
Definition
intravenous anesthetic
barbiturate |
|
|
Term
|
Definition
intravenous anesthetic
non barbiturate |
|
|
Term
|
Definition
|
|
Term
|
Definition
intravenous anesthetic
non bartituate |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
